Home/Filings/4/0001654954-25-000413
4//SEC Filing

Nardo Christopher J. 4

Accession 0001654954-25-000413

CIK 0001853816other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 6:57 PM ET

Size

5.4 KB

Accession

0001654954-25-000413

Insider Transaction Report

Form 4
Period: 2025-01-13
Nardo Christopher J.
Senior VP, CDO
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-13+20,00020,000 total
    Exercise: $1.38From: 2025-01-14Exp: 2035-01-12Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Issuer

Dermata Therapeutics, Inc.

CIK 0001853816

Entity typeother

Related Parties

1
  • filerCIK 0001870247

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 6:57 PM ET
Size
5.4 KB